Excellence is just the beginning.

Translate

French German Italian Portuguese Russian

Registry Study for Patients with Short Bowel Syndrome

Clinical Trial Title: 
Registry study for patients with short bowel syndrome.
Clinical Trial Protocol ID: 
14042501
Clinical Trial Investigator Name: 
Ece Mutlu, MD
Clinical Trial Protocol Description: 

This is an observational registry study. Information about your health will be collected during routine clinic visits approximately every six months. Each patient will be followed for at least 10 years. Two groups of patients will be recruited: patients who have been treated with Teduglutide, or who have not been treated with Teduglutide.

Clinical Trial Eligibility Criteria: 

In order to participate you must meet the following criteria:

  • Are a male or female patient, of any age, with a diagnosis of short bowel syndrome.
  • Have been on PN/IV support for at least 6 month, if you have never received teduglutide treatment.

You will be excluded from the study if any of the following criteria apply to you:

  • Have never been on PN/IV support.

This is a partial list of inclusion and exclusion criteria.

Clinical Trial Area: 
Digestive Disorders
Contact Phone: 
(312) 942-3466
Contact Name: 
GI Research